Immunic (IMUX)
(Delayed Data from NSDQ)
$1.51 USD
+0.02 (1.34%)
Updated Aug 30, 2024 04:00 PM ET
After-Market: $1.51 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
F Value A Growth B Momentum C VGM
Price, Consensus and EPS Surprise
IMUX 1.51 +0.02(1.34%)
Will IMUX be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for IMUX based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for IMUX
Immunic's (IMUX) Ulcerative Colitis Study Shows Positive Data
Immunic (IMUX) Moves to Buy: Rationale Behind the Upgrade
IMUX: What are Zacks experts saying now?
Zacks Private Portfolio Services
Other News for IMUX
Immunic to Host Multiple Sclerosis R&D Day and Participate in Scientific and Investor Conferences in September
Immunic initiated with bullish view at B. Riley, here's why
Buy Rating Affirmed for Immunic’s MS Treatment Vido with Unique Dual Mechanism and Promising Clinical Data
Immunic Stock (NASDAQ:IMUX): CEO Says “Right Time to Buy Now”
Analysts Offer Insights on Healthcare Companies: Xeris Pharmaceuticals (XERS), Aldeyra Therapeutics (ALDX) and Immunic (IMUX)